A Study of Cemdisiran in Adults With Immunoglobulin A Nephropathy (IgAN)

Status Terminated

Clinical Trial Summary

The purpose of this study is to evaluate the effect of cemdisiran on proteinuria in adults with immunoglobulin A nephropathy (IgAN), who excrete >1 gram (gm) of protein per day despite standard of care, which includes treatment with angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARB). These participants are at high risk for progression of kidney disease, which can result in end-stage renal failure.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03841448
Study type	Interventional
Source	Alnylam Pharmaceuticals
Contact
Status	Terminated
Phase	Phase 2
Start date	September 30, 2019
Completion date	June 27, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04020328` - Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency	Phase 4
Completed	`NCT02232776` - Efficacy and Safety of Losartan in Children With Ig A Nephropathy	Phase 3
Recruiting	`NCT04092491` - Study of the IgA Repertoire During IgA Deposition Nephropathy.
Not yet recruiting	`NCT05797051` - Application of Hyperspectral Imaging in the Diagnosis of Glomerular Diseases
Recruiting	`NCT05791162` - Interest of Follicular Helper Lymphocytes / Regulatory Follicular Helper Lymphocytes Ratio in IgA Nephropathy	N/A
Terminated	`NCT02647255` - Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy	Phase 2/Phase 3
Recruiting	`NCT02160132` - A Controlled Study of Steroids Therapy for Patients of IgA Nephropathy With Active Pathological Changes.	Phase 2
Recruiting	`NCT01184599` - A Prospective Study of the Kidney Protective Effect of Aliskiren in Hypertensive Patients With IgA Nephropathy	Phase 4
Active, not recruiting	`NCT00378443` - ACEi/ARB Alone Versus ACEi/ARB Plus Steroids in the Treatment of Primary IgA Nephropathy, a RCT	N/A
Completed	`NCT00396721` - Sirolimus Therapy for Poor Prognosis Immunoglobulin A Nephropathy	Phase 2
Recruiting	`NCT01802034` - Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
Recruiting	`NCT05510323` - Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD	Phase 3
Completed	`NCT00446251` - Effects of Rituximab and Mycophenolate Mofetil (MMF) on Highly Sensitized Patients Awaiting Renal Transplant	Phase 2
Active, not recruiting	`NCT04663204` - A Study of the Safety and Activity of Sparsentan for the Treatment of Incident Patients With Immunoglobulin A Nephropathy	Phase 2
Completed	`NCT00521508` - Role of Regulatory T Cells in Pathogenesis of Primary IgA Nephropathy	N/A
Completed	`NCT00446459` - Effects of Mycophenolate Mofetil (MMF) On Anti-HLA (Human Leukocyte Antigen)Antibody Levels In Patients Awaiting Cadaveric Renal Transplant.	Phase 2